Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Head-to-head comparison of GHRP-2 and GHRP-6 — mechanism, dosing, side effects, legal status, and pricing.
GHRP-2 is a synthetic hexapeptide growth hormone secretagogue that stimulates the pituitary gland to release growth hormone. It is considered one of the most potent GHRPs available and is used as a GH stimulation test diagnostic in some countries.
GHRP-6 is a synthetic hexapeptide growth hormone secretagogue known for its strong GH-releasing effects and pronounced appetite stimulation. It was one of the first GHRPs developed and is widely used in research and performance contexts.
GHRP-2
GHRP-6
Category
Legal Status
Mechanism
Dose Range
Route
Frequency
Dosing Notes
Side Effects
Contraindications
Clinical studies confirm potent, dose-dependent GH release in healthy subjects and GH-deficient patients. It is approved in Japan as a diagnostic agent (pralmorelin) for GH deficiency. It has been studied for cachexia and age-related GH decline.
Extensively studied since the 1980s, GHRP-6 was one of the first GH secretagogues characterized. Clinical trials confirm potent GH release and appetite stimulation. It has been studied for cardioprotection, wound healing, and age-related GH decline.
GHRP-2 and GHRP-6 are both in the Performance category and may have overlapping mechanisms. Researchers should review both profiles carefully, understand the mechanisms of action, and monitor the relevant biomarkers when combining compounds in the same class. As always, consult a licensed healthcare provider before making any decisions about combining research compounds.
This platform provides informational tools only, not medical advice. This comparison is for educational purposes only. Consult a licensed provider.
Disclosed Labs